Search

Author/Creator Mamolo, Carla

1. A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia. (19th November 2018)

Authors:
Ashaye, Ajibade O; Khankhel, Zarmina; Xu, Yingxin; Fahrbach, Kyle; Mokgokong, Ruth; Orme, Michelle E; Lang, Kathryn; Cappelleri, Joseph C; Mamolo, Carla
Journal:
Future oncology
Issue:
Volume 15:Number 6(2019)
Page Start:
663
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia. (2nd September 2019)

Authors:
Cortes, Jorge E.; Muresan, Bogdan; Mamolo, Carla; Cappelleri, Joseph C.; Crescenzo, Rocco J.; Su, Yun; Gambacorti-Passerini, Carlo; Heeg, Bart; Douglas Smith, B.
Journal:
Current medical research and opinion
Issue:
Volume 35:Number 9(2019)
Page Start:
1615
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. Issue 1 (December 2016)

Authors:
Papp, Kim; Bissonnette, Robert; Gooderham, Melinda; Feldman, Steven; Iversen, Lars; Soung, Jennifer; Draelos, Zoe; Mamolo, Carla; Purohit, Vivek; Wang, Cunshan; Ports, William
Journal:
BMC dermatology
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗